Express Scripts and FTC Announce Settlement

February 12, 2026

EGWP marketplace medicaid Medicare

On Feb. 4, Express Scripts and the Federal Trade Commission (FTC) announced a comprehensive resolution settlement that addresses concerns raised by the FTC. Details of the global settlement include:

  • As enforced by the settlement, our new, transparent pharmacy benefits model ensures that our patients pay the lowest available cost for their medicines, whether it is our negotiated cost, their copay, or a cash discount price.
  • TrumpRx pricing will be covered for our members so that purchases through TrumpRx will count towards their deductible upon relevant legal and regulatory changes.
    • Express Scripts is the first PBM to partner with TrumpRx, and this would be the first time TrumpRx pricing is available to patients as part of their pharmacy benefits.
  • Ensure Express Scripts’ new industry-leading and transformative price discount (rebate-free) model is widely available to employers and health plan sponsors to lower the cost of all brand medications for their members as our new standard model.
  • Ensure our new reimbursement model based off the pharmacy’s actual acquisition costs is available to retail community pharmacies, and that retail community pharmacies are compensated for other essential clinical services (e.g., certain diagnostic testing and vaccinations).
  • Ensure more lower-priced medicines, including insulins, are covered across all Express Scripts standard formularies – and that our Patient Assurance Program that caps the monthly cost of insulin at $25 is the standard for Express Scripts’ clients.
  • Support the American economy by moving rebate contracting operations conducted on Express Scripts’ behalf to the U.S. 

These are meaningful steps toward making prescription drugs more affordable for millions of families and advancing the goals we share with the administration of full transparency into prescriptions drug costs. This settlement enables us to keep moving forward, and we appreciate the Administration’s reinforcement of our commitment to pharmacy benefits that put Americans first.

perspectives

Americans continue to be satisfied with employer-sponsored coverage

A new national survey commissioned by AHIP finds American workers hold consistently positive views of employer-sponsored health coverage, with nearly 9 in 10 expressing satisfaction with their plans and a decisive 96% valuing the financial security their coverage provides. Workers view employer-provided coverage as integral to their employment decisions, with 68% ranking health insurance as […]
read more >

April 15, 2026

EGWP marketplace medicaid Medicare

Solutions

AHIP and BCBSA provide progress update on prior authorization commitments

On April 7, The Cigna Group joined other health plans in announcing an update on the industry’s progress implementing the voluntary prior authorization commitments made in partnership with the Department of Health and Human Services and CMS last year. Since June 2025, participating health plans have eliminated 11% of prior authorizations across a range of […]
read more >

April 15, 2026

EGWP marketplace medicaid Medicare

legislation

Washington lawmakers pass tax increase impacting insurers

Since returning in January, Washington lawmakers have been busy advancing a variety of tax increases to help manage significant budget shortfalls and introduce new revenue streams. One new source of revenue approved by both the Senate and House and included in the state’s budget is HB 2487, which removes a tax exemption for health plan-affiliated […]
read more >

April 15, 2026

EGWP marketplace medicaid Medicare

You may also like